Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma Details Facility's Expanded Capabilities | Contract Pharma

What are you searching for?

Sign in
Videos

MilliporeSigma Details Facility’s Expanded Capabilities

Jerome Pionchon, a mechanical engineering expert at MilliporeSigma, explains the France site's technology conversion

By: Betsy Louda

, Contract Pharma



Jerome Pionchon, a mechanical engineering expert at MilliporeSigma, spoke with Contract Pharma at Interphex 2018 about one of their sites in the south of France that experienced a major production expansion and technology conversion.

Pionchon says that in 2010, the facility was first developed for process development and the clinical manufacturing of internal projects. However, with growing demand in the biologics CDMO market, the company elected to expand capacity at its existing cGMP biomanufacturing facility in Martillac, France. In addition, the decision was also made to convert from previously-installed fixed/stainless steel equipment to single-use technologies wherever feasible. 

Additionally, since last summer, the facility operates as a fully disposable facility from upstream to downstream; a model that has reduced their environmental footprint and operating costs , but increased capacity.


 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics